4.960 <%= Resources.Global.txtUp %>
Updated 11:24:17
Change % 0.10% Stock price increasing
Change 0.005 Stock price increasing
Volume 4,801
High 4.965
Low 4.905
Open 4.905
ISIN FR0013018124
Prev close 4.955
# of shares 29.91M
Market cap 148.35M EUR

Market is open (until 16:30) - Delayed 15 min
Price development Latest 1 week 1 month 3 months 6 months 1 year
  4.96 -2.7% Stock price decreasing -0.8% Stock price decreasing -18.6% Stock price decreasing 2.2% Stock price increasing -39.4% Stock price decreasing
Powered by TradingView

News about Nicox

  • English
  • Regulatory news

Company profile

Nicox SA is a France based ophthalmic corporation. It is focused on operating in the ophthalmic market through a diversified portfolio of ophthalmic products. The company's pipeline features VESNEO for the lowering of intraocular pressure in patients with open-angle glaucoma or ocular hypertension; AC-170 for the treatment of ocular itching associated with allergic conjunctivitis; AzaSite for bacterial conjunctivitis; and BromSite for pain and inflammation after cataract surgery. The group operates internationally and is also focused on developing a pipeline of ophthalmology-focused candidates which utilize its proprietary nitric oxide-donating research platform.

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
19 June 2019 12:51:12
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190527.1 - EUROWEB3 - 2019-06-19 13:51:12 - 2019-06-19 12:51:12 - 1000 - Website: OKAY